BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2024 2:35:35 PM | Browse: 148 | Download: 628
 |
Received |
|
2024-01-07 08:13 |
|
Peer-Review Started |
|
2024-01-07 08:13 |
|
First Decision by Editorial Office Director |
|
2024-01-20 07:08 |
|
Return for Revision |
|
2024-01-20 07:08 |
|
Revised |
|
2024-02-01 08:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-03-25 01:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-03-25 05:30 |
|
Articles in Press |
|
2024-03-25 05:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-26 11:05 |
|
Publish the Manuscript Online |
|
2024-06-11 14:35 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
New perspectives in the management of diabetic nephropathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anna Psyllaki and Konstantinos Tziomalos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, The First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomal@auth.gr |
| Key Words |
Finerenone; Glucagon-like peptide 1 receptor agonists; Finerenone; Sodium-glucose cotransporter 2 inhibitors; Diabetic nephropathy; Diabetes mellitus |
| Core Tip |
The management of diabetic nephropathy evolved substantially in recent years with the accumulation of evidence showing that sodium-glucose cotransporter 2 inhibitors and potentially finerenone prevent both renal function deterioration and cardiovascular events. |
| Publish Date |
2024-06-11 14:35 |
| Citation |
Psyllaki A, Tziomalos K. New perspectives in the management of diabetic nephropathy. World J Diabetes 2024; 15(6): 1086-1090 |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i6/1086.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i6.1086 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
